L. A. Leslie, N. Gangan, H. Tan, Q. Huang, and J. Yan, “Clinico-economic burden of first-line chemoimmunotherapy by risk status in chronic lymphocytic leukemia”, J Current Med Res Opinion, vol. 5, no. 05, May 2022.